Eva Jolly: Strengthening Europe’s Cancer Clinical Trials Landscape at ECO Cancer Summit 2026
Eva Jolly / LinkedIn

Eva Jolly: Strengthening Europe’s Cancer Clinical Trials Landscape at ECO Cancer Summit 2026

Eva Jolly, Head of Head of Karolinska CCC PU at Karolinska University Hospital, shared on LinkedIn:

“Honored to participate in the plenary session ‘Strengthening Europe’s Cancer Clinical Trials Landscape‘ at the ECO Cancer Summit 2026, moderated by Christine Chomienne.

Alongside an outstanding panel:

  • Stine Bosse, Member of the European Parliament
  • Joanna Drake, Deputy Director-General, DG RTD
  • Denis Lacombe, CEO, EORTC
  • Bettina Ryll, President, MPNE
  • Alexander Roediger, VP, Oncology Policy, MSD

Strengthening Europe’s clinical trials landscape requires:

  • strong political commitment,
  • closer collaboration across countries and institutions,
  • better access to innovation,
  • and above all, a clear focus on patients.

European Cancer Centres (CCCs) and networks such as EUnetCCC – European Network of Comprehensive Cancer Centres have an important role to play in connecting expertise, building synergies and strengthening cross-border collaboration to ensure that more patients across Europe can benefit from high-quality cancer clinical trials.”

About European Cancer Summit 2026

The European Cancer Summit 2026, organized by the European Cancer Organisation (ECO), took place on November 18-19, 2026, in a hybrid format in Brussels and online, with The Hotel Brussels serving as the main venue, followed by EU-funded project events on November 20. The summit brought together policymakers, healthcare professionals, researchers, patient advocates, and industry representatives to shape European cancer care and policy.

Centered on building a healthy, equitable, resilient, and competitive European cancer care landscape, the program examined how research, digital innovation, and health policy can improve patient outcomes across the entire care pathway.

Key policy tracks and discussions addressed reimagining cancer prevention from risk reduction to early diagnosis, placing national cancer control plans above political cycles to strengthen system resilience, and expanding person-centered care through patient-reported outcome measures (PROMs) and electronic PROMs.

You can also read:

European Cancer Summit